Holtedahl, Knut
Borgquist, Lars
Donker, Gé A.
Buntinx, Frank
Weller, David
Campbell, Christine
Månsson, Jörgen
Hammersley, Victoria
Braaten, Tonje
Parajuli, Ranjan
Funding for this research was provided by:
UiT The Arctic University of Norway
Article History
Received: 11 July 2022
Accepted: 14 April 2023
First Online: 26 April 2023
Declarations
:
: The Regional Committee for Medical and Health Research Ethics of Northern Norway (REK North) approved the survey protocol (Ref 2010/1056–4). Informed consent from individual patients was waived by REK North, and thus not obtained. No personal identifiable information was attached to the data, and no patients were to be contacted. Personal data were limited to sex, date of birth and type of cancer. Only the individual GP knew the identity of any single patient. Favourable ethical approval was thereafter obtained in the other five participating countries.All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.